XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 45.87

Change

+0.10 (+0.22)%

Market Cap

CAD 0.60B

Volume

522.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-18 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.86 (+0.56%)

CAD 22.27B
ZSP:CA BMO S&P 500

+0.52 (+0.55%)

CAD 19.82B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.19 (+0.30%)

CAD 11.85B
VUN:CA Vanguard US Total Market

+0.60 (+0.51%)

CAD 11.53B
XUS:CA iShares Core S&P 500 Index ETF

+0.30 (+0.56%)

CAD 8.94B
HXS:CA Global X S&P 500 Corporate Cla..

+0.67 (+0.75%)

CAD 4.81B
VSP:CA Vanguard S&P 500 CAD hedged

+0.34 (+0.34%)

CAD 4.32B
QUU:CA Mackenzie US Large Cap Equity ..

+2.10 (+0.84%)

CAD 3.65B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.03 (+0.05%)

CAD 3.55B
XUU:CA iShares Core S&P US Total Mark..

+0.28 (+0.44%)

CAD 3.54B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.14% 12% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.14% 9% A- 52% F
Trailing 12 Months  
Capital Gain 28.45% 75% C 81% B-
Dividend Return 1.04% 28% F 12% F
Total Return 29.49% 75% C 79% B-
Trailing 5 Years  
Capital Gain 89.94% 77% C+ 85% B
Dividend Return 6.46% 15% F 11% F
Total Return 96.40% 74% C 83% B
Average Annual (5 Year Horizon)  
Capital Gain 15.38% 76% C+ 79% B-
Dividend Return 16.26% 75% C 77% C+
Total Return 0.88% 30% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.74% 37% F 54% F
Risk Adjusted Return 103.32% 61% D- 94% A
Market Capitalization 0.60B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.